Reportstack has announced a new market research publication on Antisense Therapeutics Limited - Product Pipeline Review - 2014 which provides data on the Antisense Therapeutics Limited’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from proprietary databases, Antisense Therapeutics Limited’s corporate website, SEC filings, investor presentations and featured press releases, both from Antisense Therapeutics Limited and industry-specific third party sources, put together by team of industry experts.
Scope
- Antisense Therapeutics Limited - Brief Antisense Therapeutics Limited overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Antisense Therapeutics Limited human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Antisense Therapeutics Limited with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Antisense Therapeutics Limited’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate Antisense Therapeutics Limited’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Antisense Therapeutics Limited in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Antisense Therapeutics Limited’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Antisense Therapeutics Limited.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Antisense Therapeutics Limited and identify potential opportunities in those areas.
This report is built using data and information sourced from proprietary databases, Antisense Therapeutics Limited’s corporate website, SEC filings, investor presentations and featured press releases, both from Antisense Therapeutics Limited and industry-specific third party sources, put together by team of industry experts.
Scope
- Antisense Therapeutics Limited - Brief Antisense Therapeutics Limited overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Antisense Therapeutics Limited human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Antisense Therapeutics Limited with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Antisense Therapeutics Limited’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate Antisense Therapeutics Limited’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Antisense Therapeutics Limited in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Antisense Therapeutics Limited’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Antisense Therapeutics Limited.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Antisense Therapeutics Limited and identify potential opportunities in those areas.
To view the table of contents and know more details please visit Antisense Therapeutics Limited - Product Pipeline Review - 2014.
No comments:
Post a Comment